IL1B and Insulin resistance: In this study, we observed that PU supplementation remarkably decreased gut microbiota disturbance-induced release of TNF-α and IL-1β, thus inhibiting the IKKβ/NF-κB inflammatory pathway phosphorylation and reducing the production of TNF-α and IL-1β, thereby improving insulin resistance.